Metraipolis › archive › dc_f3c74bea6ea4

CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred — Europe PMC PMID:41712626

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41712626
DOI
10.1371/journal.pbio.3003658
License (as archived)
solo-consultazione
Archived
2026-11-05T15:49:10.556Z
SHA-256 of the archived text
a164e0919ea841ac8534d7db2559a52f4f96ce712e4a13f7b881073962b58a13
Stable URL of this page
https://metraipolis.com/documento/dc_f3c74bea6ea4

How to cite

CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred — Europe PMC PMID:41712626 — Europe PMC (en), https://europepmc.org/article/MED/41712626 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3c74bea6ea4 (Metraipolis archive dc_f3c74bea6ea4, sha256 a164e0919ea841ac8534d7db2559a52f4f96ce712e4a13f7b881073962b58a13)
BibTeX
@misc{dcf3c74bea6ea4,
  title = {CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred — Europe PMC PMID:41712626},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41712626},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3c74bea6ea4; sha256 a164e0919ea841ac8534d7db2559a52f4f96ce712e4a13f7b881073962b58a13},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41712626. Agents can read the archived copy with the MCP tool read_document.